HLS Therapeutics Sees FY2026 Sales $56.000M-$60.000M vs $57.730M Est

Benzinga Newsdesk www.benzinga.com Positive 82.6%

Neg 0% Neu 0% Pos 82.6%

HLS Therapeutics (TSX:HLS) sees FY2026 sales of $56.000 million-$60.000 million vs $57.730 million analyst estimate.

Comments

No comments yet. Be the first!